Skip to main content

Advertisement

SpringerLink
Log in

Interleukin-1beta in synergism gabapentin with tramadol in murine model of diabetic neuropathy

  • Original Article
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Neuropathic pain is a complication of cancer and diabetes mellitus and the most commonly used drugs in the treatment of the diabetic neuropathic pain have only limited efficacy. The aim of this study was to evaluate the role of the biomarker interleukin-1beta (IL-1ß) in the pharmacological interaction of gabapentin with tramadol in a model of diabetic neuropathic pain. CF-1 male mice, pretreated with 200 mg/kg i.p. of streptozocin (STZ), were used and at day 3 and 7 were evaluated by the hot plate test and the spinal cord level of IL-1ß was determined. Antinociceptive interaction of the coadministration i.p. of gabapentin with tramadol, in basic of the fixed the ratio 1:1 of their ED50 values alone, was ascertained by isobolographic analysis. Tramadol was 1.13 times more potent than gabapentin in saline control mice, 1.40 times in STZ mice at 3 days and 1.28 times in STZ at 7 days. The interaction between gabapentin and tramadol was synergic, with an interaction index of 0.30 and 0.22 for mice pretreated with STZ at 3 and 7 days. The combination of gabapentin with tramadol reversed the increased concentration of IL-1β induced by STZ in diabetic neuropathic mice. These findings could help clarify the mechanism of diabetic neuropathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Bishnoi M, Bosgraaf CA, Abooj M et al (2011) Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators. Mol Pain 7:52–63

    Article  PubMed  PubMed Central  Google Scholar 

  • Cheng JK, Chiou LCh (2006) Mechanism of the antinociceptive action of gabapentin. J Pharmacol Sci 100:471–486

    Article  CAS  PubMed  Google Scholar 

  • Corona-Ramos JN, De la O-Arciniega M et al (2016) The antinociceptive effects of tramadol and/or gabapentin on rat neuropathic pain induced by a chronic constriction injury. Drug Dev Res 77:217–226

    Article  CAS  PubMed  Google Scholar 

  • Dai X, Brunson CD, Rockhold RW et al (2008) Gender differences in the antinociceptive effect of tramadol, alone or in combination with gabapentin, in mice. J Biomed Sci 15:645–651

    Article  CAS  PubMed  Google Scholar 

  • Eisenberg E, Suzan E (2014) Drug combinations in the treatment of neuropathic pain. Curr Pain Headache Rep 18:463–470

    Article  PubMed  Google Scholar 

  • Finnerup NB et al (2015) Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:162–173

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • King AJ (2012) The use of animal models in diabetes research. Br J Pharmacol 166:877–894

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kitada M, Ogura Y, Koya D (2016) Rodent models of diabetic nephropathy: their utility and limitations. Int J Nephrol Renovascular Dis 9:279–290

    Article  CAS  Google Scholar 

  • Miotto K, Cho AK, Khalil MA et al (2017) Trends on tramadol: pharmacology, metabolism and misuse. Anesth Analg 124:44–51

    Article  CAS  PubMed  Google Scholar 

  • Miranda HF, Noriega V, Prieto JC et al (2016) Antinociceptive interaction of tramadol with gabapentin in experimental mononeuropathic pain. Basic Clin Pharmacol Toxicol 119:210–214

    Article  CAS  PubMed  Google Scholar 

  • Miranda HF, Sierralta F et al (2017) Antinociceptive interaction of gabapentin with minocycline in murine diabetic neuropathy. Inflammopharmacology 25:91–97

    Article  CAS  PubMed  Google Scholar 

  • Muhammad AA, Arulselvan P, Cheah PS et al (2016) Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal model. Drug Des Dev Ther 10:1715–1730

    Article  CAS  Google Scholar 

  • Old EA, Clark AK, Malcangio M (2015) The role of glia in the spinal cord in neuropathic and inflammatory pain. Handb Exp Pharmacol 227:145–170

    Article  PubMed  Google Scholar 

  • Pabreja K, Dua K, Sharma S, Padi SS et al (2011) Minocycline attenuates the development of diabetic neuropathic pain: possible anti-inflammatory and antioxidant mechanisms. Eur J Pharmacol 661:15–21

    Article  CAS  PubMed  Google Scholar 

  • Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW et al (2008) Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70:1630–1635

    Article  CAS  PubMed  Google Scholar 

  • Vazzana M, Andreani T, Fangueiro J et al (2015) Tramadol hydrochloride: pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems. Biomed Pharmacother 70:234–238

    Article  CAS  PubMed  Google Scholar 

  • Wodarski R, Clark AK, Grist J et al (2009) Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats. Eur J Pain 13:807–811

    Article  CAS  PubMed  Google Scholar 

  • Zhou J, Zhou S (2014) Inflammation: therapeutic targets for diabetic neuropathy. Mol Neurobiol 49:536–546

    Article  CAS  PubMed  Google Scholar 

  • Zychowska M, Rojewska E, Kreiner G et al (2013) Minocycline influences the antiinflammatory interleukins and enhances the effectiveness of morphine under mice diabetic neuropathy. J Neuroimmunol 262:35–45

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was partially supported by the project Fondecyt 11140757, Chile.

Author information

Authors and Affiliations

  1. Neuroscience Department, Faculty of Medicine, University of Chile, Santiago, Chile

    H. F. Miranda & R. J. Zepeda

  2. Pharmacology Program, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile

    P. Poblete, F. Sierralta & J. C. Prieto

  3. Cardiovascular Department, Clinic Hospital, University of Chile, Santiago, Chile

    V. Noriega & J. C. Prieto

Authors
  1. H. F. Miranda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Poblete
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Sierralta
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. Noriega
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. C. Prieto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. J. Zepeda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. F. Miranda.

Ethics declarations

Conflict of interest

The authors have declared no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miranda, H.F., Poblete, P., Sierralta, F. et al. Interleukin-1beta in synergism gabapentin with tramadol in murine model of diabetic neuropathy. Inflammopharmacol 27, 151–155 (2019). https://doi.org/10.1007/s10787-018-0532-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-018-0532-7

Keywords

Search

Navigation